← Browse by Condition
Medical Condition

premature atherosclerosis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05440422 Phase 2
Recruiting

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

Enrollment
45 pts
Location
United States
Sponsor
National Institute of Arthriti...
View Trial →